Neuroimaging of insight on psilocybin and upcoming studies in older adults with low well-being

In the first half of my talk, I will present recent advances in personalized neuropharmacology, highlighting neuroimaging research linking psilocybin-induced changes in brain dynamics to individual differences in subjective experience. In the second half, I will discuss an upcoming clinical trial investigating psychedelic interventions in older adults with low well-being, with an emphasis on longitudinal changes in neuroinflammatory processes and socioaffective functioning.

Join at imt.lu/aula1